Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A nodular lymphocyte predominant Hodgkin lymphoma occurring in adults.
Biomarker and diagnostic research for adult nodular lymphocyte predominant Hodgkin lymphoma has been reported in the published literature.
No clinical trials have been registered for adult nodular lymphocyte predominant Hodgkin lymphoma.
237 publications have been identified in PubMed for adult nodular lymphocyte predominant Hodgkin lymphoma. Kisho has analyzed 153 by research type. Research spans Epidemiology / Natural History (25%), Clinical Trial Publication (24%), and Review / Meta-Analysis (22%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 39 | 25% |
Data assembled from 2 of 12 sources · Last updated Sep 21, 2026, 4:53 AM UTC
Common questions about adult nodular lymphocyte predominant Hodgkin lymphoma
Clinical study results |
36 |
24% |
Research summaries | 33 | 22% |
Testing and diagnosis research | 21 | 14% |
Laboratory research | 15 | 10% |
Patient case studies | 7 | 5% |
New treatment approaches | 2 | 1% |
Belsky JA (2026). [PMID: 42270197](https://pubmed.ncbi.nlm.nih.gov/42270197/). *Hematol Oncol Clin North Am*. [Review / Meta-Analysis]
Kearney M (2026). [PMID: 41267326](https://pubmed.ncbi.nlm.nih.gov/41267326/). *Int J Adolesc Med Health*. [Review / Meta-Analysis]
Advani RH (2026). [PMID: 41671432](https://pubmed.ncbi.nlm.nih.gov/41671432/). *J Natl Compr Canc Netw*. [Review / Meta-Analysis]
Ahmed S (2026). [PMID: 41478324](https://pubmed.ncbi.nlm.nih.gov/41478324/). *Transplant Cell Ther*. [Review / Meta-Analysis]
Nagase S (2026). [PMID: 41371409](https://pubmed.ncbi.nlm.nih.gov/41371409/). *Mod Pathol*. [Basic Science / Preclinical]
Mukae J (2026). [PMID: 41563497](https://pubmed.ncbi.nlm.nih.gov/41563497/). *Ann Hematol*. [Diagnostic / Biomarker]
Vyhlídal T (2026). [PMID: 41545469](https://pubmed.ncbi.nlm.nih.gov/41545469/). *Sci Rep*. [Epidemiology / Natural History]
Gomez F (2026). [PMID: 41791303](https://pubmed.ncbi.nlm.nih.gov/41791303/). *Cancer Genet*. [Case Report / Case Series]
Spanjaart AM (2026). [PMID: 41016707](https://pubmed.ncbi.nlm.nih.gov/41016707/). *Transplant Cell Ther*. [Epidemiology / Natural History]
Baron K (2026). [PMID: 42166512](https://pubmed.ncbi.nlm.nih.gov/42166512/). *Cancer J*. [Review / Meta-Analysis]